AVTX Similar Chart Price Prediction
The price of AVTX is predicted to go up -4.49%, based on the high correlation periods with MKSI. The similarity of these two price pattern on the periods is 90.49%.
AVTX
MKSI
Down: -4.49%Similarity: 90.49%
AVTX Revenue Forecast
AVTX EPS Forecast
AVTX Analyst's Forecast
Kambiz Yazdi
Jefferies
Strong Buy
2025-03-25
Price Target
$23
Upside
+165.44%
Jefferies analyst Kambiz Yazdi initiated coverage of Avalo Therapeutics with a Buy rating and $23 price target. Avalo is a clinical stage biotechnology company focused on immunology and inflammation led by a veteran management team, the analyst tells investors in a research note. The firm says Avalo's lead asset AVTX-009 is an IL-1beta antibody in Phase 2 for the treatment of moderate to severe hidradenitis suppurativa with topline data expected in 2026. It thinks AVTX-009 is de-risked in part by lutikizumab data and that Avalo has an angle to show a differentiated profile.
Alex Thompson
Stifel
Strong Buy
2025-03-25
Price Target
$36
Upside
+315.46%
Julian Harrison
BTIG
Strong Buy
2024-12-19
Price Target
$40
Upside
+330.11%
